850074-44-1

Basic information

• Product Name: ethyl 6-formylbenzothiophene-2-carboxylate
• Synonyms: ethyl 6-formyl-1-benzothiophene-2-carboxylate; Ethyl-6-formyl-1-benzothiophen-2-carboxylat
• CAS NO: 850074-44-1
• Molecular Formula: C₁₂H₁₀O₃S
• Molecular Weight: 234.27
• Mol File: 850074-44-1.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 384.8°C at 760 mmHg
• Flash Point: 186.5°C
• Density: 1.308g/cm³
• Vapor Pressure: 3.97E-06mmHg at 25°C
• Refractive Index: 1.653
• CAS DataBase Reference: ethyl 6-formylbenzothiophene-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 6-formylbenzothiophene-2-carboxylate(850074-44-1)
• EPA Substance Registry System: ethyl 6-formylbenzothiophene-2-carboxylate(850074-44-1)

Safety Data

• Hazardous Substances Data: 850074-44-1(Hazardous Substances Data)

Upstream product

• 153813-69-5 methyl 4-formyl-3-nitrobenzoate 
• 850074-43-0 benzo[b]thiophene-2,6-dicarboxylic acid 2-ethyl ester 
• 850074-42-9 2-ethyl 6-methyl benzo[b]thiophene-2,6-dicarboxylate 
• 850072-65-0 6-hydroxymethyl-benzo[b]thiophene-2-carboxylic acid ethyl ester 

Downstream Products

• 947513-38-4 C₂₀H₂₁NSO₂ 
• 850072-65-0 6-hydroxymethyl-benzo[b]thiophene-2-carboxylic acid ethyl ester 
• 947513-35-1 C₁₈H₁₇NSO₂ 
• 850074-74-7 6-(benzylamino-methyl)-benzo[b]thiophene-2-carboxylic acid ethyl ester 
• 850074-68-9 6-[(4-methoxy-benzylamino)-methyl]-benzo[b]thiophene-2-carboxylic acid ethyl ester 
• 913739-27-2 C₂₅H₂₉N₃O₃S 

Relevant articles and documents

ORTHO AMINOAMIDES FOR THE TREATMENT OF CANCER

Compounds of formula are HDAC inhibitors. These compounds are useful for the treatment of diseases such as cancer in humans or animals.

BENZOTHIOPHENE HYDROXAMIC ACID DERIVATIVES

The present invention relates to a novel class of hydroxamic acid derivatives. The hydroxamic acid compounds can be used to treat cancer. The hydroxamic acid compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing t

THIOPHENE AND BENZOTHIOPHENE HYDROXAMIC ACID DERIVATIVES

The present invention relates to a novel class of hydroxamic acid derivatives having a benzothiophene or thiophene backbone. The hydroxamic acid compounds can be used to treat cancer. The hydroxamic acid compounds can also inhibit historic deacetylase and